Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Shirouchi Y, Mishima Y, Fukuhara S, Makita S, Izutsu K, Terui Y, Suzuki T, Kawasaki A, Miyake T, Maruyama D.

DOI: 10.1007/s10147-026-03110-2
Published: 2026-07-02
Container: Int J Clin Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10147-026-03110-2,
  title = {Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.},
  author = {Shirouchi Y and  Mishima Y and  Fukuhara S and  Makita S and  Izutsu K and  Terui Y and  Suzuki T and  Kawasaki A and  Miyake T and  Maruyama D.},
  year = {2026},
  journal = {Int J Clin Oncol},
  doi = {10.1007/s10147-026-03110-2},
  url = {https://doi.org/10.1007/s10147-026-03110-2}
}

RIS

TY  - JOUR
TI  - Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
AU  - Shirouchi Y
AU  -  Mishima Y
AU  -  Fukuhara S
AU  -  Makita S
AU  -  Izutsu K
AU  -  Terui Y
AU  -  Suzuki T
AU  -  Kawasaki A
AU  -  Miyake T
AU  -  Maruyama D.
PY  - 2026
JO  - Int J Clin Oncol
DO  - 10.1007/s10147-026-03110-2
UR  - https://doi.org/10.1007/s10147-026-03110-2
ER  -

APA

Y, S., Y, M., S, F., S, M., K, I., Y, T., T, S., A, K., T, M., & D., M. (2026). Phase I study of glofitamab in Japanese patients with relapsed or refractory B-cell non-Hodgkin lymphoma.. Int J Clin Oncol. https://doi.org/10.1007/s10147-026-03110-2

Source records

europe-pmc · retrieved 2026-09-26T10:56:36.600Z